American Healthcare REIT (AHR) Upgraded to Strong Buy: Here's Why
UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $71
American Healthcare REIT (AHR) Is Up 8.20% in One Week: What You Should Know
Citigroup Maintains Buy on American Healthcare REIT, Raises Price Target to $67
RBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $66
American Healthcare REIT Inc (AHR) (Q3 2026) Earnings Call Highlights: Raised Guidance and 11 ...
American Healthcare REIT (AHR): Here’s Why Wall Street Is Bullish
American Healthcare REIT: 3 Key Takeaways for Long-Term Investors
Guidance Raise Could Be A Game Changer For American Healthcare REIT Stock (AHR)
Healthcare REIT (AHR) Q3 2026 Earnings Call Transcript
American Healthcare REIT (AHR) Stock Could Be 48% Undervalued Despite Raised Guidance
American Healthcare REIT (AHR) Could Be 10% Below Fair Value On Q3 Results
American Healthcare REIT Q3 Earnings Call Highlights
American Healthcare REIT, Inc. (AHR) Q3 2026 Earnings Call Transcript
American Healthcare REIT Establishes New $1.75B ATM Equity Offering Program, Replacing Prior Sales Agreement
American Healthcare REIT Q3 2026 Earnings Call Transcript
American Healthcare REIT (NYSE:AHR) Q3 2026 Results: Raised Guidance and Strong SHOP NOI Growth
American Healthcare REIT: Q3 Earnings Snapshot
American Healthcare REIT Announces Third Quarter 2026 Results; Increases Full Year 2026 Guidance
American Healthcare REIT Raises FY2026 FFO Guidance from $2.15-$2.19 to $2.23-$2.26 vs $2.17 Est
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.